You are here: Industry Insights > WHO

News List

World Health Organization SAGE Issues Interim Recommendations for Novavax COVID-19 Vaccine prnasia
December 22, 2021
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the World Health Organization...
Sputnik V due to submit vaccine data to WHO this month expresspharma
December 22, 2021
Moscow rushed to approve the shot for domestic use last year and it has been exported to countries around the world, but it has still not been certified by either the WHO or the EMA...
World Health Organization Grants Second Emergency Use Listing for Novavax COVID-19 Vaccine prnasia
December 21, 2021
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the World Health Organization (WHO)...
Novavax and SII obtain WHO Emergency Use Listing for Covid-19 vaccine Pharmaceutical-Technology
December 21, 2021
Novavax and its partner Serum Institute of India (SII) have obtained Emergency Use Listing (EUL) from the World Health Organization (WHO) for the former’s recombinant nanoparticle protein-based Covid-19 vaccine with Matrix-M adjuvant, NVX-CoV2373.
COVID-19 vaccines may be less effective against Omicron, says WHO expresspharma
December 17, 2021
The WHO, in its weekly epidemiological update, said that more data was needed to better understand the extent to which Omicron may evade immunity derived from either vaccines or previous infection.
CHMP recommend approval for Roche’s COVID-19 therapy PharmaTimes
December 08, 2021
According to clinical data, Roche’s new COVID-19 treatment Actemra/RoActemra lowered mortality risk in critically ill adult patients.
COVID-19 health concern continues to decline in November: Poll Pharmaceutical-Technology
December 07, 2021
The health concern over COVID-19 declined for the third consecutive month in November, shows the COVID-19 concern index, which is measured by responses to an ongoing poll Verdict launched in March 2020.
WHO Approves First Long-Acting Device to Shield Women From HIV Drugs
December 02, 2021
With HIV a continuing threat to women's health, the World Health Organization (WHO) has approved the first long-acting device to protect women from sexually transmitted HIV.
WHO update on Omicron WorldPharmaNews
December 01, 2021
On 26 November 2021, WHO designated the variant B.1.1.529 a variant of concern, named Omicron, on the advice of WHO's Technical Advisory Group on Virus Evolution (TAG-VE). This decision was based on the evidence presented to the TAG-VE that Omicron...
Novavax seeks emergency use listing from WHO for Covid-19 vaccine Pharmaceutical-Business-Review
November 09, 2021
Novavax has completed the rolling submission to the World Health Organization (WHO) for emergency use listing (EUL) of its Covid-19 vaccine candidate, NVX-CoV2373.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page